Your browser doesn't support javascript.
loading
Circulation of respiratory viruses during the COVID-19 pandemic in The Gambia
Sheikh Jarju; Elina Senghore; Helen Brotherton; Alasana Saidykhan; Samba Jallow; Ebrima Krubally; Edrisa Sinjanka; Morris Ngor Ndene; Fabakary Bajo; Musa M Sanyang; Binta Saidy; Alasana Bah; Karen Forrest; Ed Clarke; Umberto Dalessandro; Effua Usuf; Carla Cerami; Anna Roca; Beate Kampmann; Thushan de Silva.
Afiliação
  • Sheikh Jarju; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Elina Senghore; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Helen Brotherton; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Alasana Saidykhan; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Samba Jallow; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Ebrima Krubally; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Edrisa Sinjanka; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Morris Ngor Ndene; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Fabakary Bajo; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Musa M Sanyang; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Binta Saidy; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Alasana Bah; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Karen Forrest; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Ed Clarke; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Umberto Dalessandro; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Effua Usuf; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Carla Cerami; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Anna Roca; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Beate Kampmann; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
  • Thushan de Silva; Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine
Preprint em En | PREPRINT-MEDRXIV | ID: ppmedrxiv-22278521
ABSTRACT
In many countries, non-pharmaceutical interventions to limit SARS-CoV-2 transmission resulted in significant reductions in other respiratory viruses. However, similar data from Africa are limited. We explored the extent to which viruses such as influenza and rhinovirus co-circulated with SARS-CoV-2 in The Gambia during the COVID-19 pandemic. Between April 2020 and March 2022, respiratory viruses were detected using RT-PCR in nasopharyngeal swabs from 1397 participants with influenza-like illness. Overall virus positivity was 44.2%, with prevalence higher in children <5 years (80%) compared to children aged 5-17 years (53.1%), adults aged 18-50 (39.5%) and >50 years (39.9%), p<0.0001. After SARS-CoV-2 (18.3%), rhinoviruses (10.5%) and influenza viruses (5.5%) were the most prevalent. SARS-CoV-2 positivity was lower in children <5 (4.3%) and 5-17 years (12.7%) than in adults aged 18-50 (19.3%) and >50 years (24.3%), p<0.0001. In contrast, rhinoviruses were most prevalent in children <5 years (28.7%), followed by children aged 5-17 (15.8%), adults aged 18-50 (8.3%) and >50 years (6.3%), p<0.0001. Four SARS-CoV-2 waves occurred, with 36.1%-52.4% SARS-CoV-2 positivity during peak months. Influenza infections were observed in both 2020 and 2021 during the rainy season as expected (peak positivity 16.4%-23.5%). Peaks of rhinovirus were asynchronous to the months when SARS-CoV-2 and influenza peaked.
Licença
cc_by_nc_nd
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Preprint
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Preprint